Stocksigma LogoStocksigma Logo

Sai Life Sciences Fully Utilizes Rs 9,500 Million IPO Fresh Proceeds

CRISIL Ratings released the final monitoring agency report for Sai Life Sciences Ltd for the quarter ended 30th Sep'26, confirming 100% utilization of its

Sai Life Sciences Fully Utilizes Rs 9,500 Million IPO Fresh Proceeds

Sai Life Sciences Ltd 路 Others (Uncategorized) 路 12 Nov 2026, 4:36 pm

Sai Life Sciences Fully Utilizes Rs 9,500 Million IPO Fresh Proceeds CRISIL Ratings released the final monitoring agency report for Sai Life Sciences Ltd for the quarter ended 30th Sep'26, confirming 100% utilization of its Rs 9,500.00 million gross IPO fresh issue proceeds. Allocations included Rs 7,200.00 million toward debt repayment, Rs 380.73 million for issue expenses, and Rs 1,919.27 million for general corporate purposes, including Rs 20.43 million deployed for equipment and machinery during the quarter following savings in issue expenses. Monitoring account balances stand at nil with zero deviations.

Original exchange filing (PDF)

More announcements from Sai Life Sciences Ltd

All Sai Life Sciences Ltd announcements